Heparin-induced thrombocytopenia (HIT) is an adverse prothrombotic disorder caused by
an immune response to complexes of platelet factor 4 and polyanions. The clinical …

Heparin-induced thrombocytopenia (HIT) is the most common, immune-mediated adverse
drug reaction affecting blood cells. It is of high clinical relevance, as in patients developing …

Heparin‐induced thrombocytopenia (HIT), typically occurring in the second week of heparin
therapy, is an antibody‐mediated adverse drug reaction associated with increased …

Heparin-induced thrombocytopenia (HIT), typically occurring in the second week of heparin
therapy, is an antibody-mediated adverse drug reaction associated with increased …

Heparin-induced thrombocytopenia (HIT) is a life-and limb-threatening prothrombotic,
immune-mediated adverse drug effect that occurs with unfractionated heparin and to a …

Heparin-induced thrombocytopenia (HIT) is the most important immunological drug reaction
that patients face today. HIT typically develops in patients 5 days after starting heparin …

Heparin-induced thrombocytopenia (HIT) is a potentially devastating immune mediated
adverse drug reaction caused by the emergence of antibodies that activate platelets in the …

Thrombocytopenia following heparin administration can be associated with an immune
reaction, now referred to as heparin-induced thrombocytopenia. HIT is essentially a …

Heparin induced thrombocytopenia (HIT) remains the most severe adverse effect of heparin
therapy. Recently, new information has been uncovered regarding the pathogenesis of this …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic and potentially devastating
complication of heparin therapy due to formation of platelet-activating antibodies against …